Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Orasure Technologies Inc (OSUR)  
$5.49 0.01 (0.18%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 71,730,000
Market Cap: 393.80(M)
Last Volume: 668,077 Avg Vol: 963,466
52 Week Range: $4.4 - $8.35
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  621
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Orasure Technologies is engaged in two segments Diagnostics, and Molecular Solutions. Co.'s Diagnostics business primarily consists of the development, manufacture, marketing and sale of simple, easy to use diagnostic products and specimen collection devices using its proprietary technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Co.'s Molecular Solutions products primarily consist of collection kits and services used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 100,000 170,200
Total Buy Value $0 $0 $492,810 $781,522
Total People Bought 0 0 1 5
Total Buy Transactions 0 0 1 5
Total Shares Sold 0 24,129 25,887 25,887
Total Sell Value $0 $194,219 $205,646 $205,646
Total People Sold 0 1 2 2
Total Sell Transactions 0 1 2 2
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 823
  Page 4 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shulkin David Director   –       •      –    2022-05-16 4 A $5.25 $105,000 D/D 20,000 30,550     -
   Shulkin David Director   –       •      –    2022-05-16 4 D $5.25 $14,411 D/D (2,745) 10,550     -
   Datin James A Director   –       •      –    2022-05-16 4 A $5.25 $105,000 D/D 20,000 51,101     -
   Whitaker Anne Clem Director   –       •      –    2022-05-16 4 A $5.25 $105,000 D/D 20,000 30,563     -
   Lancaster Ronny B Director   –       •      –    2022-05-16 4 A $5.25 $105,000 D/D 20,000 54,782     -
   Hobbs Eamonn P Director   –       •      –    2022-05-16 4 A $5.25 $105,000 D/D 20,000 61,452     -
   Hobbs Eamonn P Director   –       •      –    2022-05-16 4 D $5.25 $12,647 D/D (2,409) 41,452     -
   Nibauer Lisa President of Diagnostics   •       –      –    2022-05-11 4 D $5.06 $8,118 D/D (1,606) 123,479     -
   Shulkin David Director   –       •      –    2022-04-06 4 D $6.71 $15,077 D/D (2,247) 13,295     -
   Gagliano Nancy J DirectorInterim CEO   •       •      –    2022-04-01 4 A $0.00 $0 D/D 114,074 120,245     -
   Gagliano Nancy J DirectorInterim CEO   •       •      –    2022-04-01 4 D $6.75 $29,646 D/D (4,392) 20,986     -
   Datin James A Director   –       •      –    2022-03-25 4 D $6.92 $4,400 D/D (636) 31,101     -
   Datin James A Director   –       •      –    2022-03-25 4 A $6.92 $16,249 D/D 2,349 31,737     -
   Nibauer Lisa President-Diagnostics   •       –      –    2022-02-01 4 A $8.86 $306,166 D/D 34,556 125,085     -
   Nibauer Lisa President-Diagnostics   •       –      –    2022-02-01 4 D $8.86 $23,089 D/D (2,606) 90,529     -
   Miller Michele Marie VP, Finance and Controller   •       –      –    2022-02-01 4 A $8.86 $60,000 D/D 6,772 64,625     -
   Miller Michele Marie VP, Finance and Controller   •       –      –    2022-02-01 4 D $8.86 $14,725 D/D (1,662) 57,853     -
   Gleason Scott Interim CFO/SVP IR   •       –      –    2022-02-01 4 A $8.86 $259,997 D/D 29,345 98,505     -
   Gallagher Agnieszka General Counsel & CCO   •       –      –    2022-02-01 4 A $8.86 $337,123 D/D 38,050 90,584     -
   Tang Stephen S Phd President and CEO   •       –      –    2022-02-01 4 D $8.86 $268,644 D/D (30,321) 349,793     -
   Tang Stephen S Phd President and CEO   •       –      –    2022-02-01 4 A $8.86 $1,062,429 D/D 119,913 360,018     -
   Weber Kathleen Gallagher President - Molecular Sol   •       –      –    2022-02-01 4 D $8.86 $84,400 D/D (9,526) 206,059     -
   Weber Kathleen Gallagher President - Molecular Sol   •       –      –    2022-02-01 4 A $8.86 $363,703 D/D 41,050 208,841     -
   Weber Kathleen Gallagher President - Molecular Sol   •       –      –    2022-01-05 4 A $8.21 $499,997 D/D 60,901 174,535     -
   Miller Michele Marie VP, Finance and Controller   •       –      –    2022-01-05 4 A $8.21 $350,001 D/D 42,631 59,515     -
  823 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 4 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us